DrugRisk Update: Jury Awards Bladder Cancer Victim $6.5 Million in Actos Lawsuit

New York, NY (PRWEB) May 02, 2013

The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for patients who have taken the diabetes medication Actos. A jury in the first Actos trial last week decided that the maker of the drug didnt properly warn patients of bladder cancer risks****.

The goal of DrugRisk is to improve the safety of patients taking popular prescription drugs by providing the most up-to-date warnings, recalls, studies and legal news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice.

DrugRisk contains warnings from experts such as the FDA and European Medicines Agency*, who have warned that long-term use of Actos may be associated with an increased bladder cancer risk. The drug has also been banned in France and Germany**.

Although Actos remains on the market in the United States, the resource center notes that as many as 3,000 patients have filed an Actos lawsuit against drug maker Takeda Pharmaceuticals alleging they developed bladder cancer***.

Now, DrugRisk has learned that, in the first of those lawsuits to go to trial, a jury last week decided that drug maker Takeda failed to properly warn of Actos dangers, and awarded Jack Cooper, who developed bladder cancer after taking the drug, $6.5 million for his damages****.

Anyone affected by bladder cancer after taking Actos is urged to contact DrugRisk or speak with a lawyer about their legal rights as soon as possible. Lawyers are still helping those affected file claims.

Due to the specialized nature of drug injury litigation, however, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

To learn more about the studies linking Actos to bladder cancer, as well as side effects and legal news, or to speak with a lawyer, visit http://www.DrugRisk.com today.

*FDA 6/15/11; fda.gov/Drugs/DrugSafety/ucm259150.htm; European Medicines Association, 7/21/11; http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&mid=WC0b01ac058004d5c1 **CBS News 6/10/11; cbsnews.com/8301-504763_162-20070492-10391704.html ***Bloomberg News 3/5/13; bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html; Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles). ****Japan Times, 4/29/13; japantimes.co.jp/news/2013/04/29/national/takeda-loses-cancer-suit-over-actos-2/#.UX529HB6WfQ

The rest is here:
DrugRisk Update: Jury Awards Bladder Cancer Victim $6.5 Million in Actos Lawsuit